Sofia Maysel-Auslender

1.1k total citations
18 papers, 400 citations indexed

About

Sofia Maysel-Auslender is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Sofia Maysel-Auslender has authored 18 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Sofia Maysel-Auslender's work include Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Sofia Maysel-Auslender is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Sofia Maysel-Auslender collaborates with scholars based in Israel, Canada and United States. Sofia Maysel-Auslender's co-authors include Gad Keren, Jacob George, Michal Entin‐Meer, Jeremy Ben‐Shoshan, Arnon Afek, Iris Barshack, Ardon Rubinstein, Jonathan Semo, Shmuel Schwartzenberg and Aviv Shaish and has published in prestigious journals such as PLoS ONE, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Sofia Maysel-Auslender

18 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Maysel-Auslender Israel 12 180 125 124 93 74 18 400
Rui‐Yi Lu China 8 202 1.1× 183 1.5× 147 1.2× 107 1.2× 68 0.9× 13 477
Servé Olieslagers Netherlands 11 210 1.2× 137 1.1× 96 0.8× 75 0.8× 80 1.1× 15 519
Jesús M. Gómez-Salinero United States 14 418 2.3× 59 0.5× 156 1.3× 59 0.6× 70 0.9× 19 599
Naohiro Ohashi Japan 7 178 1.0× 116 0.9× 100 0.8× 48 0.5× 77 1.0× 9 433
Abraham Behrmann United States 8 240 1.3× 95 0.8× 134 1.1× 46 0.5× 91 1.2× 9 635
Takanori Kusuyama Japan 11 140 0.8× 41 0.3× 109 0.9× 93 1.0× 109 1.5× 20 405
Joseph Janicki United States 9 119 0.7× 47 0.4× 136 1.1× 55 0.6× 91 1.2× 15 420
Elena Nefyodova Belgium 8 150 0.8× 49 0.4× 64 0.5× 62 0.7× 80 1.1× 11 371
Ingrid A.M. Relou Netherlands 12 113 0.6× 148 1.2× 120 1.0× 55 0.6× 119 1.6× 14 442
Marine Bignon France 7 284 1.6× 52 0.4× 174 1.4× 160 1.7× 52 0.7× 8 564

Countries citing papers authored by Sofia Maysel-Auslender

Since Specialization
Citations

This map shows the geographic impact of Sofia Maysel-Auslender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Maysel-Auslender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Maysel-Auslender more than expected).

Fields of papers citing papers by Sofia Maysel-Auslender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Maysel-Auslender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Maysel-Auslender. The network helps show where Sofia Maysel-Auslender may publish in the future.

Co-authorship network of co-authors of Sofia Maysel-Auslender

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Maysel-Auslender. A scholar is included among the top collaborators of Sofia Maysel-Auslender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Maysel-Auslender. Sofia Maysel-Auslender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Holmes, Tyson H., Sofia Maysel-Auslender, Scott D. Boyd, et al.. (2023). Acute Respiratory Illness Is Associated with Memory T Cell Differentiation and Other Immune Cell Changes in an Age-Associated Manner. ImmunoHorizons. 7(9). 611–618. 1 indexed citations
2.
Semo, Jonathan, Sara Shimoni, Tamar Ben-Mordechai, et al.. (2014). Experimental Myocardial Infarction Induces Altered Regulatory T Cell Hemostasis, and Adoptive Transfer Attenuates Subsequent Remodeling. PLoS ONE. 9(12). e113653–e113653. 66 indexed citations
3.
Golan, Shani, Michal Entin‐Meer, Sofia Maysel-Auslender, et al.. (2014). Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment. BMC Research Notes. 7(1). 617–617. 8 indexed citations
4.
Semo, Jonathan, Arnon Afek, Camila Avivi, et al.. (2013). The 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice. European Heart Journal. 35(45). 3212–3223. 34 indexed citations
5.
Havakuk, Ofer, Michal Entin‐Meer, Jeremy Ben‐Shoshan, et al.. (2013). Effect of vitamin D analogues on acute cardiorenal syndrome: a laboratory rat model.. PubMed. 15(11). 693–7. 6 indexed citations
6.
Entin‐Meer, Michal, Jeremy Ben‐Shoshan, Sofia Maysel-Auslender, et al.. (2012). Accelerated Renal Fibrosis in Cardiorenal Syndrome Is Associated with Long-Term Increase in Urine Neutrophil Gelatinase-Associated Lipocalin Levels. American Journal of Nephrology. 36(2). 190–200. 22 indexed citations
7.
Hochhauser, Edith, Michal Entin‐Meer, Einat Birk, et al.. (2012). Islet-1 gene delivery improves myocardial performance after experimental infarction. Atherosclerosis. 223(2). 284–290. 12 indexed citations
8.
Wasserman, Asaf, Jeremy Ben‐Shoshan, Michal Entin‐Meer, et al.. (2012). Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis.. PubMed. 14(10). 620–3. 26 indexed citations
9.
George, Jacob, Irena Wigler, S Oren, et al.. (2010). Decreased levels of CCR3 in CD4+ lymphocytes of rheumatoid arthritis patients.. PubMed. 28(4). 462–7. 6 indexed citations
10.
Pando, Rakefet, Iris Barshack, Galia Luboshits, et al.. (2009). The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat. Cardiovascular Pathology. 19(2). 94–101. 5 indexed citations
11.
Pando, Rakefet, Yelena Cheporko, Ronit Haklai, et al.. (2009). Ras inhibition attenuates myocardial ischemia–reperfusion injury. Biochemical Pharmacology. 77(10). 1593–1601. 12 indexed citations
12.
Afek, Arnon, Sofia Maysel-Auslender, Adi Mor, et al.. (2009). Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvascular Research. 77(3). 364–369. 41 indexed citations
13.
Ben‐Shoshan, Jeremy, Arnon Afek, Sofia Maysel-Auslender, et al.. (2009). HIF-1α Overexpression and Experimental Murine Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 29(5). 665–670. 41 indexed citations
14.
Ben‐Shoshan, Jeremy, Michal Entin‐Meer, Sofia Maysel-Auslender, et al.. (2009). A potential role for islet-1 in post-natal angiogenesis and vasculogenesis. Thrombosis and Haemostasis. 103(1). 188–197. 29 indexed citations
15.
Ben‐Shoshan, Jeremy, Sofia Maysel-Auslender, Galia Luboshits, et al.. (2008). Hypoxia-Inducible Factor-1α and -2α Additively Promote Endothelial Vasculogenic Properties. Journal of Vascular Research. 46(4). 299–310. 11 indexed citations
16.
Ben‐Shoshan, Jeremy, Shulamit Schwartz, Galia Luboshits, et al.. (2008). Constitutive Expression of HIF-1α and HIF-2α in Bone Marrow Stromal Cells Differentially Promotes Their Proangiogenic Properties. Stem Cells. 26(10). 2634–2643. 25 indexed citations
17.
Schwartzenberg, Shmuel, Ariel Finkelstein, Jacob N. Ablin, et al.. (2008). Circulating Apoptotic Progenitor Cells in Patients with Congestive Heart Failure. PLoS ONE. 3(9). e3238–e3238. 26 indexed citations
18.
Schwartzenberg, Shmuel, et al.. (2007). Circulating Apoptotic Progenitor Cells. Arteriosclerosis Thrombosis and Vascular Biology. 27(5). e27–31. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026